Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

The aim of this cross-sectional, case-control study is the complex assessment of areal and volumetric bone mineral density (BMD), fracture risk, vitamin D status and bone turnover markers, and its association with disease-related variables.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Case-control study.

Case-control study

Compares people with an outcome against people without it, examining exposures.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Characterization of bone metabolism in hungarian psoriatic arthritis patients: a case: control study

Source: Article title.

All volunteers were briefed verbally about the aim of the study and the procedures involved, and all study participants gave written informed consent.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Characterization of bone metabolism in hungarian psoriatic arthritis patients: a case-control study

Case-control study · BMC Musculoskeletal Disorders · 2021

Original publication title

Characterization of bone metabolism in hungarian psoriatic arthritis patients: a case: control study

Zsófia Pethő; Edit Kalina; Zoltán Pap; Katalin Hodosi; Rebeka Falcsik; Ádám Balogh; Zoltán Szekanecz; Harjit Pal Bhattoa

© The Author(s) 2021

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

In the studied PsA cohort, disease activity was an independent predictor of 10-year probability for a major osteoporotic fracture, and complemented assessment of volumetric and areal BMD assured better efficacy at identifying those with low bone mineral density.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Skeletal manifestations are predominant in psoriatic arthritis (PsA). The aim of this cross-sectional, case-control study is the complex assessment of areal and volumetric bone mineral density (BMD), fracture risk, vitamin D status and bone turnover markers, and its association with disease-related variables.

Source: Background

Abstract: What methods does the paper describe?

Lumbar spine (L1-L4) and femoral neck (FN) areal, and distal radius (DR) volumetric BMD, 10-year probability of major and hip osteoporotic fracture as assessed by the fracture risk assessment (FRAX) tool, markers of bone metabolism and disease activity were assessed.

Source: Methods

Abstract: Results

Upon comparison of the disease and age: and sex-matched control groups, there was a statistically significant difference in FN areal (0.952 (0.607 to 1.292) g/cm2 vs. 1.016 (0.760 to 1.550) g/cm2; p = 0.001) and DR total volumetric (284.3 (138.9 to 470.3) mg/cm3 vs. 367.0 (287.0 to 412.0) mg/cm3; p < 0.001) BMD, 10 year probability for major osteoporotic (3.7% (0.7 to 32%) vs. 2.6% (0 to 17.5%); p = 0.003) and hip (0.4% (0 to 16%) vs. 0.05% (0 to 6.1%); p = 0.002) fracture and 25-hydroxyvitamin D status (47.5 (10 to 120) nmol/L vs. 64 (10 to 137; p < 0.001) nmol/L).

As compared to areal assessment, volumetric BMD measurements identified a significantly higher number of patients with low bone mineral density (T-Score ≤ − 1.00) (34% vs. 88%, p < 0.001). Upon multiple linear regression analysis, disease activity score, as determined by DAS28 assessment, was an independent predictor of 10-year probability for major osteoporotic fracture (B (95%CI) = 1.351 (0.379 to 2.323); p = 0.007).

Source: Results

Abstract: Conclusion

In the studied PsA cohort, disease activity was an independent predictor of 10-year probability for a major osteoporotic fracture, and complemented assessment of volumetric and areal BMD assured better efficacy at identifying those with low bone mineral density.

Source: Conclusion
Authors’ abstract

Background

Skeletal manifestations are predominant in psoriatic arthritis (PsA). The aim of this cross-sectional, case-control study is the complex assessment of areal and volumetric bone mineral density (BMD), fracture risk, vitamin D status and bone turnover markers, and its association with disease-related variables.

Methods

Lumbar spine (L1-L4) and femoral neck (FN) areal, and distal radius (DR) volumetric BMD, 10-year probability of major and hip osteoporotic fracture as assessed by the fracture risk assessment (FRAX) tool, markers of bone metabolism and disease activity were assessed.

Results

Upon comparison of the disease and age: and sex-matched control groups, there was a statistically significant difference in FN areal (0.952 (0.607 to 1.292) g/cm2 vs. 1.016 (0.760 to 1.550) g/cm2; p = 0.001) and DR total volumetric (284.3 (138.9 to 470.3) mg/cm3 vs. 367.0 (287.0 to 412.0) mg/cm3; p < 0.001) BMD, 10 year probability for major osteoporotic (3.7% (0.7 to 32%) vs. 2.6% (0 to 17.5%); p = 0.003) and hip (0.4% (0 to 16%) vs. 0.05% (0 to 6.1%); p = 0.002) fracture and 25-hydroxyvitamin D status (47.5 (10 to 120) nmol/L vs. 64 (10 to 137; p < 0.001) nmol/L).

As compared to areal assessment, volumetric BMD measurements identified a significantly higher number of patients with low bone mineral density (T-Score ≤ − 1.00) (34% vs. 88%, p < 0.001). Upon multiple linear regression analysis, disease activity score, as determined by DAS28 assessment, was an independent predictor of 10-year probability for major osteoporotic fracture (B (95%CI) = 1.351 (0.379 to 2.323); p = 0.007).

Conclusion

In the studied PsA cohort, disease activity was an independent predictor of 10-year probability for a major osteoporotic fracture, and complemented assessment of volumetric and areal BMD assured better efficacy at identifying those with low bone mineral density.

Publication and source details

Original title: Characterization of bone metabolism in hungarian psoriatic arthritis patients: a case: control study

Zsófia Pethő; Edit Kalina; Zoltán Pap; Katalin Hodosi; Rebeka Falcsik; Ádám Balogh; Zoltán Szekanecz; Harjit Pal Bhattoa

BMC Musculoskeletal Disorders · 2021

© The Author(s) 2021https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.http://dx.doi.org/10.13039/501100003549Hungarian Scientific Research FundK105073European Union and the State of Hungary TAMOP-4.2.4.A/2-11/1-2012-0001European Union GINOP-2.3.2-15-2016-00015European Union GINOP-2.3.2-15-2016-00050

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T14:42:30.191639+00:00

DOI: 10.1186/s12891-021-03952-z · PMC7805054